Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | CLK1 | P49759 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20984472 | 0.92 | GAA (0.71) | GAAKDM4ETDP1ALDH1A1MAPT | |
| SCHEMBL10589209 | 0.85 | GAA (0.64) | GAAKDM4ETDP1ALDH1A1MAPT | |
| SCHEMBL9504533 | 0.83 | ALDH1A1 (0.61) | GAAKDM4ETDP1CTSDALDH1A1 | |
| SCHEMBL29676195 | 0.81 | ALDH1A1 (0.61) | GAAALDH1A1MAPTLMNAHTT | |
| SCHEMBL11326923 | 0.81 | ALDH1A1 (0.61) | GAAALDH1A1MAPTLMNAHTT | |
| SCHEMBL14518046 | 0.81 | GAA (0.68) | GAAKDM4ETDP1ALDH1A1MAPT | |
| SCHEMBL2233791 | 0.80 | GAA (0.60) | GAAALDH1A1MAPTLMNAHTT | |
| SCHEMBL29163015 | 0.80 | GAA (0.65) | GAAALDH1A1MAPTLMNACLK1 | |
| SCHEMBL15568571 | 0.80 | GAA (0.60) | GAAKDM4ETDP1ALDH1A1MAPT | |
| SCHEMBL9036508 | 0.78 | ALDH1A1 (0.71) | GAAKDM4EALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661912-B9 | COMPOUNDS FOR TREATING INFECTIONS | HORITZONTS TECNOLOGICS HUNGARY KORLATOLT FELELOSSEGU TARSASAG (HU) | 2024-02-28 | — | — | EP | disclosed |
| EP-3661912-B1 | COMPOUNDS FOR TREATING INFECTIONS | HORITZONTS TECNOLOGICS HUNGARY KORLATOLT FELELOSSEGU TARSASAG (HU) | 2023-11-22 | — | — | EP | disclosed |
| US-20230348365-A1 | COMPOUNDS FOR TREATING INFECTIONS | ARTS & CIÈNCIES EUROPA (AD) | 2023-11-02 | — | — | US | disclosed |
| US-11584710-B2 | Compounds for treating infections | HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁG (HU) | 2023-02-21 | — | — | US | disclosed |
| US-20210155578-A1 | COMPOUNDS FOR TREATING INFECTIONS | ARTS & CIÈNCIES EUROPA (AD) | 2021-05-27 | — | — | US | disclosed |
| WO-2019025426-A1 | COMPOUNDS FOR TREATING INFECTIONS | HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁG (HU) | 2019-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210155578-A1 | COMPOUNDS FOR TREATING INFECTIONS | DPM1, TREH, MPO | GAA 244/4885KDM4E 2557/4885TDP1 4137/4885 |
| US-20230348365-A1 | COMPOUNDS FOR TREATING INFECTIONS | DPM1, TREH, MPO | GAA 244/4885KDM4E 2557/4885TDP1 4137/4885 |
| US-11584710-B2 | Compounds for treating infections | DPM1, TREH, MPO | GAA 244/4885KDM4E 2557/4885TDP1 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.